Cardiawave has developed a unique non-invasive ultrasound therapy for the treatment of calcific aortic stenosis.
Our mission is to improve the quality of patient care by offering medical devices for non-invasive therapies.
Discover our job offers!
Aortic stenosis is one of the most common and serious valve disease problems. It is a life-threatening disease caused by the narrowing of the opening of the aortic valve.
most frequent cardiovascular disease in developed countries (1) (2).
In Europe and North America combined, 2.6M patients suffer from symptomatic severe
Aortic valve stenosis, in the population aged 75Y and above. This number will increase to 3M by 2031 (1).
health spending to treat symptomatic aortic valve disease in the United States of America (4).
of severe symptomatic aortic stenosis patients remain untreated in the United States of America (5).
To treat calcific aortic stenosis, Cardiawave has developed a Non-Invasive Ultrasound Therapy (NIUT). NIUT consists in softening the aortic valve, not replacing it. No surgery is required.
Our unique approach could represent both an alternative for patients non eligible for SAVR/TAVR (Surgical Aortic Valve Replacement) and a complementary approach to current procedures to prepare overly calcified aortic valves before the deployment of a TAVR.